439 related articles for article (PubMed ID: 27930092)
1. Inflammatory Bowel Disease Meets Systems Biology: A Multi-Omics Challenge and Frontier.
Palmieri O; Mazza T; Castellana S; Panza A; Latiano T; Corritore G; Andriulli A; Latiano A
OMICS; 2016 Dec; 20(12):692-698. PubMed ID: 27930092
[TBL] [Abstract][Full Text] [Related]
2. Integrating omics: the future of IBD?
Fiocchi C
Dig Dis; 2014; 32 Suppl 1():96-102. PubMed ID: 25531360
[TBL] [Abstract][Full Text] [Related]
3. Systems biology in inflammatory bowel diseases: ready for prime time.
Polytarchou C; Koukos G; Iliopoulos D
Curr Opin Gastroenterol; 2014 Jul; 30(4):339-46. PubMed ID: 24837229
[TBL] [Abstract][Full Text] [Related]
4. Proteomics and metabolomics in inflammatory bowel disease.
Yau Y; Leong RW; Zeng M; Wasinger VC
J Gastroenterol Hepatol; 2013 Jul; 28(7):1076-86. PubMed ID: 23489082
[TBL] [Abstract][Full Text] [Related]
5. Recent Advances in the Etiopathogenesis of Inflammatory Bowel Disease: The Role of Omics.
Stylianou E
Mol Diagn Ther; 2018 Feb; 22(1):11-23. PubMed ID: 28900867
[TBL] [Abstract][Full Text] [Related]
6. Integrating omics for a better understanding of Inflammatory Bowel Disease: a step towards personalized medicine.
Kumar M; Garand M; Al Khodor S
J Transl Med; 2019 Dec; 17(1):419. PubMed ID: 31836022
[TBL] [Abstract][Full Text] [Related]
7. Systems biology approaches for inflammatory bowel disease: emphasis on gut microbial metabolism.
Moco S; Candela M; Chuang E; Draper C; Cominetti O; Montoliu I; Barron D; Kussmann M; Brigidi P; Gionchetti P; Martin FP
Inflamm Bowel Dis; 2014 Nov; 20(11):2104-14. PubMed ID: 25029616
[TBL] [Abstract][Full Text] [Related]
8. Multi-omics analysis of inflammatory bowel disease.
Huang H; Vangay P; McKinlay CE; Knights D
Immunol Lett; 2014 Dec; 162(2 Pt A):62-8. PubMed ID: 25131220
[TBL] [Abstract][Full Text] [Related]
9. Proteomics and Lipidomics in Inflammatory Bowel Disease Research: From Mechanistic Insights to Biomarker Identification.
Titz B; Gadaleta RM; Lo Sasso G; Elamin A; Ekroos K; Ivanov NV; Peitsch MC; Hoeng J
Int J Mol Sci; 2018 Sep; 19(9):. PubMed ID: 30223557
[TBL] [Abstract][Full Text] [Related]
10. Big data in IBD: big progress for clinical practice.
Seyed Tabib NS; Madgwick M; Sudhakar P; Verstockt B; Korcsmaros T; Vermeire S
Gut; 2020 Aug; 69(8):1520-1532. PubMed ID: 32111636
[TBL] [Abstract][Full Text] [Related]
11. Etiopathogenesis of inflammatory bowel disease: today and tomorrow.
de Souza HSP
Curr Opin Gastroenterol; 2017 Jul; 33(4):222-229. PubMed ID: 28402995
[TBL] [Abstract][Full Text] [Related]
12. High-throughput omics technologies in inflammatory bowel disease.
Xu C; Shao J
Clin Chim Acta; 2024 Mar; 555():117828. PubMed ID: 38355001
[TBL] [Abstract][Full Text] [Related]
13. Challenges in IBD Research: Precision Medicine.
Denson LA; Curran M; McGovern DPB; Koltun WA; Duerr RH; Kim SC; Sartor RB; Sylvester FA; Abraham C; de Zoeten EF; Siegel CA; Burns RM; Dobes AM; Shtraizent N; Honig G; Heller CA; Hurtado-Lorenzo A; Cho JH
Inflamm Bowel Dis; 2019 May; 25(Suppl 2):S31-S39. PubMed ID: 31095701
[TBL] [Abstract][Full Text] [Related]
14. The IBD interactome: an integrated view of aetiology, pathogenesis and therapy.
de Souza HSP; Fiocchi C; Iliopoulos D
Nat Rev Gastroenterol Hepatol; 2017 Dec; 14(12):739-749. PubMed ID: 28831186
[TBL] [Abstract][Full Text] [Related]
15. What's new in IBD therapy: An "omics network" approach.
Fiocchi C; Iliopoulos D
Pharmacol Res; 2020 Sep; 159():104886. PubMed ID: 32428668
[TBL] [Abstract][Full Text] [Related]
16. Omics Approaches to Identify Potential Biomarkers of Inflammatory Diseases in the Focal Adhesion Complex.
Brooks J; Watson A; Korcsmaros T
Genomics Proteomics Bioinformatics; 2017 Apr; 15(2):101-109. PubMed ID: 28373027
[TBL] [Abstract][Full Text] [Related]
17. Artificial intelligence applications in inflammatory bowel disease: Emerging technologies and future directions.
Gubatan J; Levitte S; Patel A; Balabanis T; Wei MT; Sinha SR
World J Gastroenterol; 2021 May; 27(17):1920-1935. PubMed ID: 34007130
[TBL] [Abstract][Full Text] [Related]
18. Omics and Multi-Omics in IBD: No Integration, No Breakthroughs.
Fiocchi C
Int J Mol Sci; 2023 Oct; 24(19):. PubMed ID: 37834360
[TBL] [Abstract][Full Text] [Related]
19. The application of multi-omics and systems biology to identify therapeutic targets in chronic kidney disease.
Cisek K; Krochmal M; Klein J; Mischak H
Nephrol Dial Transplant; 2016 Dec; 31(12):2003-2011. PubMed ID: 26487673
[TBL] [Abstract][Full Text] [Related]
20. The diagnosis of inborn errors of metabolism by an integrative "multi-omics" approach: A perspective encompassing genomics, transcriptomics, and proteomics.
Stenton SL; Kremer LS; Kopajtich R; Ludwig C; Prokisch H
J Inherit Metab Dis; 2020 Jan; 43(1):25-35. PubMed ID: 31119744
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
